Condition
Addiction, Opioid
Total Trials
5
Recruiting
2
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Recruiting2
Completed1
Active Not Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05315492Not ApplicableCompletedPrimary
Strengthening Community Addiction Services in Vietnam
NCT05343793Not ApplicableActive Not RecruitingPrimary
Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)
NCT06540105Recruiting
Leveraging Artificial Intelligence and Multi-Omics Data to Predict Opioid Addiction
NCT04276792Not ApplicableRecruitingPrimary
Community Opioid Innovation Network (JCOIN): TCU Clinical Research Center
NCT05908305Phase 4Unknown
Impact of Tramadol Addiction On Dental Anesthesia Success
Showing all 5 trials